U.S. Markets closed

Khiron Life Sciences Corp. (KHRN.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.4000+0.0100 (+2.56%)
At close: 3:40PM EDT
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.3900
Open0.4050
Bid0.4000 x 0
Ask0.4050 x 0
Day's Range0.3900 - 0.4050
52 Week Range0.3000 - 1.2000
Volume106,015
Avg. Volume239,619
Market Cap47.019M
Beta (5Y Monthly)1.99
PE Ratio (TTM)N/A
EPS (TTM)-0.2950
Earnings DateMay 01, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est1.20
  • External Review by Honourable Pepita G. Capriolo
    CNW Group

    External Review by Honourable Pepita G. Capriolo

    Laicization of Brian BoucherMONTREAL, Oct. 23, 2020 /CNW Telbec/ - The Honourable Pepita G.

  • Khiron Appoints Joel Friedman to Succeed Wendy Kaufman as Chief Financial Officer
    PR Newswire

    Khiron Appoints Joel Friedman to Succeed Wendy Kaufman as Chief Financial Officer

    Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQX: KHRNF), (Frankfurt: A2JMZC), a medical cannabis leader with core operations in Latin America and Europe announced the appointment, effective October 16, of Joel Friedman as CFO following the resignation of Wendy Kaufman, the Company's CFO since July, 2019. Ms. Kaufman is departing to return to the mining industry where she has spent the greater part of her executive career.

  • Desjardins launches a new $50 million impact fund for developing countries
    CNW Group

    Desjardins launches a new $50 million impact fund for developing countries

    LÉVIS, QC, Oct. 16, 2020 /CNW Telbec/ - Desjardins Group is proud to announce the establishment of the Aequitas fund, a private investment fund focused on impact finance which will be used to promote gender equality, combat climate change and contribute to achieving other Sustainable Development Goals (SDGs) through financial inclusion.